Literature DB >> 9660389

Increased bone resorption during the first year after stroke.

Y Sato1, H Kuno, M Kaji, Y Ohshima, T Asoh, K Oizumi.   

Abstract

BACKGROUND AND
PURPOSE: Significant bone mineral density (BMD) reduction occurs in stroke patients on the hemiplegic side compared with the intact side. To elucidate the pathogenesis of hip fractures in this population, we measured serum markers of bone metabolism and BMD in the stroke patients within 1 year (early group) and between 1 and 2 years after onset of hemiplegia (long-term group).
METHODS: Sera were collected from 51 patients from the early group and 93 patients from the long-term group. All patients had hemiplegia. Sera were assayed for pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen (ICTP; a bone resorption marker) and bone Gla protein (a bone formation marker). The z score of BMD was determined in both second metacarpals.
RESULTS: Serum ICTP concentrations (ng/mL) were higher in the early group (15.4+/-4.1) than in the long-term group (6.7+/-4.4). Bone Gla protein was normal or low in both groups. Multiple regression analysis identified Barthel Index, degree of hemiplegia, and illness duration as independent determinants of ICTP in the early group, whereas Barthel Index, degree of hemiplegia, and serum calcium were determinants of ICTP in the long-term group. There were statistically significant correlations between the z score of the hemiplegic side and age, Barthel Index, degree of hemiplegia, illness duration, 25-hydroxyvitamin D (25-OHD), and ICTP in the early group and between the z score and degree of hemiplegia and 25-OHD level in the long-term group.
CONCLUSIONS: The pathogenesis of reduced BMD differed between the early and long-term stroke groups. These results suggest that in the early group, increased bone resorption caused by immobilization was responsible for osteopenia on the hemiplegic side, whereas the degree of hemiplegia and 25-OHD level were the determinants of osteopenia in the long-term group.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9660389     DOI: 10.1161/01.str.29.7.1373

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  12 in total

1.  Muscle strength is a determinant of bone mineral content in the hemiparetic upper extremity: implications for stroke rehabilitation.

Authors:  Marco Y C Pang; Janice J Eng
Journal:  Bone       Date:  2005-07       Impact factor: 4.398

2.  Compromised bone strength index in the hemiparetic distal tibia epiphysis among chronic stroke patients: the association with cardiovascular function, muscle atrophy, mobility, and spasticity.

Authors:  M Y C Pang; M C Ashe; J J Eng
Journal:  Osteoporos Int       Date:  2009-10-31       Impact factor: 4.507

3.  Chronic effects of stroke on hip bone density and tibial morphology: a longitudinal study.

Authors:  F M H Lam; M Bui; F Z H Yang; M Y C Pang
Journal:  Osteoporos Int       Date:  2015-09-02       Impact factor: 4.507

4.  Biochemical markers of bone turnover: potential use in the investigation and management of postmenopausal osteoporosis.

Authors:  P Szulc; P D Delmas
Journal:  Osteoporos Int       Date:  2008-07-16       Impact factor: 4.507

Review 5.  (Sub)clinical cardiovascular disease is associated with increased bone loss and fracture risk; a systematic review of the association between cardiovascular disease and osteoporosis.

Authors:  Debby den Uyl; Mike T Nurmohamed; Lilian Hd van Tuyl; Hennie G Raterman; Willem F Lems
Journal:  Arthritis Res Ther       Date:  2011-01-17       Impact factor: 5.156

6.  Denosumab for treatment of immobilization-related hypercalcaemia in a patient with advanced renal failure.

Authors:  Esther de Beus; Walther H Boer
Journal:  Clin Kidney J       Date:  2012-10-07

7.  Risks of all-cause and site-specific fractures among hospitalized patients with COPD.

Authors:  Kuang-Ming Liao; Fu-Wen Liang; Chung-Yi Li
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

8.  Change of Bone Mineral Density and Relationship to Clinical Parameters in Male Stroke Patients.

Authors:  Hui Dong Kim; Sae Hyun Kim; Dong Kyu Kim; Ho Joong Jeong; Young Joo Sim; Ghi Chan Kim
Journal:  Ann Rehabil Med       Date:  2016-12-30

9.  Bone structure and remodelling in stroke patients: early effects of zoledronate.

Authors:  Kenneth E S Poole; Shobna Vedi; Irene Debiram; Collette Rose; Jon Power; Nigel Loveridge; Elizabeth A Warburton; Jonathan Reeve; Juliet Compston
Journal:  Bone       Date:  2008-12-11       Impact factor: 4.398

10.  Poststroke hip fracture: prevalence, clinical characteristics, mineral-bone metabolism, outcomes, and gaps in prevention.

Authors:  Alexander Fisher; Wichat Srikusalanukul; Michael Davis; Paul Smith
Journal:  Stroke Res Treat       Date:  2013-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.